Literature DB >> 26436436

Ethnic, Racial, and Socioeconomic Disparities in Retinoblastoma.

Bao Truong1, Adam L Green1, Paola Friedrich1, Karina B Ribeiro2, Carlos Rodriguez-Galindo1.   

Abstract

IMPORTANCE: Most children with retinoblastoma in the United States are diagnosed as having a large intraocular tumor burden that requires intensive ocular-salvage treatment or enucleation.
OBJECTIVE: To investigate the effect of socioeconomic status, race, and ethnicity on the extent of disease and the outcomes of retinoblastoma. DESIGN, SETTING, AND PARTICIPANTS: A population-based review of 18 Surveillance, Epidemiology, and End Results (SEER) registries. From January 1, 2000, through December 31, 2010, 830 cases of retinoblastoma were recorded for children aged 0 to 9 years. Data were collected and analyzed from January 1, 2000, through December 31, 2010, with the last follow-up on December 31, 2010. EXPOSURES: County-based socioeconomic variables analyzed included poverty level, educational attainment, language isolation, crowding, unemployment, and percentage of immigrants. MAIN OUTCOMES AND MEASURES: Extent of disease, ocular outcome, and children's survival.
RESULTS: Of the 830 individuals included, Hispanic children had a higher percentage of extraocular disease (86 of 261 [33.0%] vs. 102 of 510 non-Hispanic children [20.0%]; odds ratio [OR], 1.97 [95% CI, 1.38-2.79]). The percentage of extraocular cases was also higher in counties with the following low socioeconomic status indicators: higher vs. lower poverty status (115 of 413 [27.8%] vs. 73 of 358 [20.4%]; OR, 1.51; 95% CI, 1.06-2.14); lower vs. higher educational attainment (115 of 400 [28.7%] vs. 73 of 371 [19.7%]; OR, 1.65; 95% CI, 1.16-2.34); higher vs. lower levels of crowding (124 of 398 [31.2%] vs. 64 of 373 [17.2%]; OR, 2.18; 95% CI, 1.53-3.13); higher vs. lower unemployment (119 of 411 [28.9%] vs. 69 of 360 [19.2%]; OR, 1.72; 95% CI, 1.21-2.45); higher vs. lower language isolation (117 of 388 [30.2%] vs. 71 of 383 [18.5%]; OR, 1.89; 95% CI, 1.34-2.70); and higher vs. lower percentage of immigrants (109 of 386 [28.2%] vs. 79 of 385 [20.5%]; OR, 1.52; 95% CI, 1.08-2.16). Higher rates of enucleation were associated with low educational attainment (265 of 401 [66.1%] vs 309 of 421 [73.4%]; OR, 1.42; 95% CI, 1.04-1.93), a higher level of crowding (316 of 416 [76.0%] vs. 258 of 406 [63.5%]; OR, 1.81; 95% CI, 1.32-2.48), and Hispanic origin (202 of 271 [74.5%]; OR, 1.41; 95% CI, 1.01-1.98). Relative survival at 5 years was lower among black compared with non-Hispanic white children (92.7% vs. 99.2%; P < .001). CONCLUSIONS AND RELEVANCE: Significant disparities exist in the care and outcomes of children with retinoblastoma. A low socioeconomic status negatively affects disease extent and ocular outcomes, presumably by limiting access to primary and cancer-directed care. Hispanic children in particular have more advanced disease and higher rates of enucleation.

Entities:  

Mesh:

Year:  2015        PMID: 26436436     DOI: 10.1001/jamapediatrics.2015.2360

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  25 in total

1.  Follow-up and Time to Treatment in an Urban Cohort of Children with Sleep-Disordered Breathing.

Authors:  Vandra C Harris; Anne R Links; Julia M Kim; Jonathan Walsh; David E Tunkel; Emily F Boss
Journal:  Otolaryngol Head Neck Surg       Date:  2018-04-24       Impact factor: 3.497

2.  Socioeconomic Status, Race/Ethnicity, and Health Disparities in Children and Adolescents in a Mixed Rural-Urban Community-Olmsted County, Minnesota.

Authors:  Kara A Bjur; Chung-Il Wi; Euijung Ryu; Chris Derauf; Sheri S Crow; Katherine S King; Young J Juhn
Journal:  Mayo Clin Proc       Date:  2019-01       Impact factor: 7.616

3.  Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations.

Authors:  Sarah B Whittle; Michelle A Lopez; Heidi V Russell
Journal:  Pediatr Blood Cancer       Date:  2019-04-16       Impact factor: 3.167

4.  Death Within 1 Month of Diagnosis in Childhood Cancer: An Analysis of Risk Factors and Scope of the Problem.

Authors:  Adam L Green; Elissa Furutani; Karina Braga Ribeiro; Carlos Rodriguez Galindo
Journal:  J Clin Oncol       Date:  2017-03-06       Impact factor: 44.544

5.  Associations Between Race/Ethnicity and US Childhood and Adolescent Cancer Survival by Treatment Amenability.

Authors:  Arash Delavar; Justin M Barnes; Xiaoyan Wang; Kimberly J Johnson
Journal:  JAMA Pediatr       Date:  2020-05-01       Impact factor: 16.193

6.  Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children's Oncology Group Study.

Authors:  Adam L Green; Murali Chintagumpala; Mark Krailo; Bryan Langholz; Daniel Albert; Ralph Eagle; Myles Cockburn; Patricia Chevez-Barrios; Carlos Rodriguez-Galindo
Journal:  Ophthalmology       Date:  2016-06-01       Impact factor: 12.079

7.  Pediatric neuro-oncology survival disparities in California.

Authors:  Tabitha Cooney; Paul G Fisher; Li Tao; Christina A Clarke; Sonia Partap
Journal:  J Neurooncol       Date:  2018-02-07       Impact factor: 4.130

8.  Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014.

Authors:  Nitya Rajeshuni; Talhah Zubair; Cassie A Ludwig; Darius M Moshfeghi; Prithvi Mruthyunjaya
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

9.  Retinoblastoma: A Sixteen-Year Review of the Presentation, Treatment, and Outcome from a Tertiary Care Institute in Northern India.

Authors:  Usha Singh; Deeksha Katoch; Savleen Kaur; Mangat Ram Dogra; Deepak Bansal; Rakesh Kapoor
Journal:  Ocul Oncol Pathol       Date:  2017-07-05

10.  Impact of Race, Ethnicity, and Socioeconomic Status over Time on the Long-term Survival of Adolescent and Young Adult Hodgkin Lymphoma Survivors.

Authors:  Amy M Berkman; Clark R Andersen; Vidya Puthenpura; J Andrew Livingston; Sairah Ahmed; Branko Cuglievan; Michelle A T Hildebrandt; Michael E Roth
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-07-08       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.